Cargando…

Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide

The melanocortin-4 receptor (MC4R), a hypothalamic master regulator of energy homeostasis and appetite, is a class A G-protein-coupled receptor and a prime target for the pharmacological treatment of obesity. Here, we present cryo-electron microscopy structures of MC4R–Gs-protein complexes with two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heyder, Nicolas A., Kleinau, Gunnar, Speck, David, Schmidt, Andrea, Paisdzior, Sarah, Szczepek, Michal, Bauer, Brian, Koch, Anja, Gallandi, Monique, Kwiatkowski, Dennis, Bürger, Jörg, Mielke, Thorsten, Beck-Sickinger, Annette G., Hildebrand, Peter W., Spahn, Christian M. T., Hilger, Daniel, Schacherl, Magdalena, Biebermann, Heike, Hilal, Tarek, Kühnen, Peter, Kobilka, Brian K., Scheerer, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563958/ https://www.ncbi.nlm.nih.gov/pubmed/34561620 http://dx.doi.org/10.1038/s41422-021-00569-8

Ejemplares similares

Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective
por: Heyder, Nicolas, et al.
Publicado: (2019)

A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation
por: Reininghaus, Nanina, et al.
Publicado: (2022)

Interactions of the Melanocortin-4 Receptor with the Peptide Agonist NDP-MSH
por: Chapman, Kathryn L., et al.
Publicado: (2010)

Evaluation of Pharmacological Rescue of Melanocortin-4 Receptor Nonsense Mutations by Aminoglycoside
por: Höpfner, Friederike, et al.
Publicado: (2022)

Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor
por: Kleinau, Gunnar, et al.
Publicado: (2020)

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
por: Saleh, Noureldin, et al.
Publicado: (2018)

The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
por: Bräunig, Julia, et al.
Publicado: (2018)

Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
por: Haws, Robert, et al.
Publicado: (2020)

SAT026 Melanocortin Receptors In The Earliest Chordates?
por: Ji, Ren-Lei, et al.
Publicado: (2023)

Melanocortin Receptor Accessory Protein 2-Induced Adrenocorticotropic Hormone Response of Human Melanocortin 4 Receptor
por: Soletto, Lucia, et al.
Publicado: (2018)

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
por: Daini, Eleonora, et al.
Publicado: (2023)

Differential Signaling Profiles of MC4R Mutations with Three Different Ligands
por: Paisdzior, Sarah, et al.
Publicado: (2020)

Activation of the Melanocortin-1 Receptor by NDP-MSH Attenuates Oxidative Stress and Neuronal Apoptosis through PI3K/Akt/Nrf2 Pathway after Intracerebral Hemorrhage in Mice
por: Fu, Siming, et al.
Publicado: (2020)

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
por: Collet, Tinh-Hai, et al.
Publicado: (2017)

Antimicrobial Properties of α-MSH and Related Synthetic Melanocortins
por: Catania, A., et al.
Publicado: (2006)

Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
por: Speck, David, et al.
Publicado: (2022)

NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice
por: Wu, Xuan, et al.
Publicado: (2019)

Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis
por: Ferraz Barbosa, Bárbara, et al.
Publicado: (2023)

A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2
por: Paisdzior, Sarah, et al.
Publicado: (2021)

Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants
por: Speck, David, et al.
Publicado: (2022)

ODP607 Long-term Efficacy of Setmelanotide in Patients With POMC or LEPR Deficiency Obesity
por: Clément, Karine, et al.
Publicado: (2022)

Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies
por: Wabitsch, Martin, et al.
Publicado: (2022)

Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide
por: Wabitsch, Martin, et al.
Publicado: (2022)

Effect of NDP-α-MSH on PPAR-γ and –β Expression and Anti-Inflammatory Cytokine Release in Rat Astrocytes and Microglia
por: Carniglia, Lila, et al.
Publicado: (2013)

Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83
por: Müller, Anne, et al.
Publicado: (2016)

Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype
por: Kamermans, Alwin, et al.
Publicado: (2019)

Ring Finger Protein 11 Inhibits Melanocortin 3 and 4 Receptor Signaling
por: Müller, Anne, et al.
Publicado: (2016)

A Phase 3 Trial in Participants With Obesity Due to Bardet-Biedl Syndrome or Alström Syndrome: Efficacy and Safety of the Melanocortin 4 Receptor Agonist Setmelanotide
por: Haws, Robert, et al.
Publicado: (2021)

Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency
por: Clément, Karine, et al.
Publicado: (2021)

Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for β-MSH and desacetyl α-MSH in energy homeostasis
por: Kirwan, Peter, et al.
Publicado: (2018)

Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiency
por: Kühnen, Peter, et al.
Publicado: (2022)

α-MSH and melanocortin receptors at early ontogeny in European sea bass (Dicentrarchus labrax, L.)
por: Tsalafouta, A., et al.
Publicado: (2017)

Structural–Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work
por: Kleinau, Gunnar, et al.
Publicado: (2017)

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids
por: Clemson, Christine M., et al.
Publicado: (2016)

Activation of the Melanocortin-4 receptor signaling by α-MSH stimulates nerve-dependent mouse digit regeneration
por: Xu, Hanqian, et al.
Publicado: (2021)

The Pathogenic TSH β-Subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR
por: Kalveram, Laura, et al.
Publicado: (2019)

Crystal Structure of the β(2)Adrenergic Receptor-Gs protein complex
por: Rasmussen, Søren G.F., et al.
Publicado: (2011)

The melanocortin receptor type 3 agonist d‐Trp(8)‐γMSH decreases inflammation and muscle wasting in arthritic rats
por: Gómez‐SanMiguel, Ana Belen, et al.
Publicado: (2015)

Dual NDP52 Function in Persistent CSFV Infection
por: Fan, Shuangqi, et al.
Publicado: (2020)

NDP-related retinopathies: clinical phenotype of female carriers
por: Huang, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g68ns7o911qsl27n34g7aagbmv